A detailed history of Centiva Capital, LP transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Centiva Capital, LP holds 23,358 shares of PACB stock, worth $45,548. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,358
Holding current value
$45,548
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.2 - $2.17 $28,029 - $50,686
23,358 New
23,358 $39,000
Q4 2023

Feb 14, 2024

BUY
$5.97 - $10.36 $110,564 - $191,867
18,520 New
18,520 $181,000
Q3 2022

Nov 14, 2022

BUY
$3.93 - $8.57 $279,780 - $610,106
71,191 New
71,191 $414,000
Q3 2021

Nov 15, 2021

SELL
$24.86 - $35.02 $217,176 - $305,934
-8,736 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$22.3 - $36.02 $194,812 - $314,670
8,736 New
8,736 $305,000
Q1 2020

May 15, 2020

SELL
$2.36 - $5.26 $177,000 - $394,500
-75,000 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$4.6 - $5.57 $345,000 - $417,750
75,000 New
75,000 $386,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $438M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Centiva Capital, LP Portfolio

Follow Centiva Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.